Press Release
Apr 17, 2019
(Denver)—The IASLC is on the air – with its first-ever podcast “Lung Cancer Considered.”
Those interested in lung cancer research and clinical developments can now tune in to "Lung Cancer Considered" twice each month for the latest research and news on the study of lung cancer. "Lung Cancer Considered" will feature the researchers, healthcare professionals, patients and advocates who are making a difference in the advancement of the study and treatment of thoracic malignancies.
Click here to listen to the first episode of “Lung Cancer Considered,” The Evolution of Small Cell Lung Cancer, on SoundCloud. “Lung Cancer Considered” can also be listened to on the news page on the website IASLC.org.
The IASLC chose noted oncologist H. Jack West, MD, director of medical oncology and operations at City of Hope, Duarte, Calif. to launch the podcast program as host. City of Hope is a leader in the research and treatment of cancer, diabetes and other serious diseases and an NCI-designated Comprehensive Cancer Center.
“Dr. West is active and engaged as an IASLC member and in both the medical and patient experiences with lung cancer, is savvy about technology and podcasting, and shares our goal of disseminating information about lung cancer,” said Dave Mesko, CEO of the IASLC. “Podcasting is an ideal format for dialogue about lung cancer research as it allows the researcher to go into greater detail about study design, outcomes and scientific nuance that our audience will appreciate.
“I’ve always respected the IASLC, its mission and the way the organization presents content to the oncology profession. I’m excited to work with them on the “Lung Cancer Considered” podcast,” said West.
Future episodes of “Lung Cancer Considered” focus on research at IASLC meetings, including the World Conference on Lung Cancer in Barcelona this September, as well as current and breaking news on topics related to lung cancer research.
West has extensive experience podcasting and creating audio content on lung cancer for his own website, West Wind Podcast and Beacon Medical Interchange, as well as for other organizations.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.